Anti-DCD/ AIDD-1/ DSEP functional antibody

Anti-DCD/ AIDD-1/ DSEP functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to DCD/DCD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0848-Ab-1/ GM-Tg-hg-SE0848-Ab-2Anti-Human DCD monoclonal antibodyHuman
GM-Tg-rg-SE0848-Ab-1/ GM-Tg-rg-SE0848-Ab-2Anti-Rat DCD monoclonal antibodyRat
GM-Tg-mg-SE0848-Ab-1/ GM-Tg-mg-SE0848-Ab-2Anti-Mouse DCD monoclonal antibodyMouse
GM-Tg-cynog-SE0848-Ab-1/ GM-Tg-cynog-SE0848-Ab-2Anti-Cynomolgus/ Rhesus macaque DCD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0848-Ab-1/ GM-Tg-felg-SE0848-Ab-2Anti-Feline DCD monoclonal antibodyFeline
GM-Tg-cang-SE0848-Ab-1/ GM-Tg-cang-SE0848-Ab-2Anti-Canine DCD monoclonal antibodyCanine
GM-Tg-bovg-SE0848-Ab-1/ GM-Tg-bovg-SE0848-Ab-2Anti-Bovine DCD monoclonal antibodyBovine
GM-Tg-equg-SE0848-Ab-1/ GM-Tg-equg-SE0848-Ab-2Anti-Equine DCD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0848-Ab-1/ GM-Tg-hg-SE0848-Ab-2; GM-Tg-rg-SE0848-Ab-1/ GM-Tg-rg-SE0848-Ab-2;
GM-Tg-mg-SE0848-Ab-1/ GM-Tg-mg-SE0848-Ab-2; GM-Tg-cynog-SE0848-Ab-1/ GM-Tg-cynog-SE0848-Ab-2;
GM-Tg-felg-SE0848-Ab-1/ GM-Tg-felg-SE0848-Ab-2; GM-Tg-cang-SE0848-Ab-1/ GM-Tg-cang-SE0848-Ab-2;
GM-Tg-bovg-SE0848-Ab-1/ GM-Tg-bovg-SE0848-Ab-2; GM-Tg-equg-SE0848-Ab-1/ GM-Tg-equg-SE0848-Ab-2
Products NameAnti-DCD monoclonal antibody
Formatmab
Target NameDCD
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DCD benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0848-Ag-1Recombinant multi-species DCD/ AIDD-1/ DSEP protein
    ORF Viral VectorvGMLP004746human DCD Lentivirus particle
    ORF Viral VectorpGMLP004746human DCD Lentivirus plasmid


    Target information

    Target IDGM-SE0848
    Target NameDCD
    Gene ID117159,704163
    Gene Symbol and SynonymsAIDD,DCD,DCD-1,DSEP,HCAP,PIF
    Uniprot AccessionP81605
    Uniprot Entry NameDCD_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000161634
    Target ClassificationN/A

    The target: DCD, gene name: DCD, also named as AIDD-1, DSEP, HCAP, PIF, DCD. This antimicrobial gene encodes a secreted protein that is subsequently processed into mature peptides of distinct biological activities. The C-terminal peptide is constitutively expressed in sweat and has antibacterial and antifungal activities. The N-terminal peptide, also known as diffusible survival evasion peptide, promotes neural cell survival under conditions of severe oxidative stress. A glycosylated form of the N-terminal peptide may be associated with cachexia (muscle wasting) in cancer patients. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.